Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China
Yanjuan Jiang,Jianting Zhu,Xiaoyang Lai
DOI: https://doi.org/10.2147/DMSO.S424267
2023-08-19
Abstract:Yanjuan Jiang, 1 Jianting Zhu, 2 Xiaoyang Lai 1 1 Department of Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China; 2 Department of Intensive Care Unit, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China Correspondence: Xiaoyang Lai, Department of Endocrinology, The Second Affiliated Hospital of Nanchang University, No. 1, Minde Road, Donghu District, Nanchang, 330006, People's Republic of China, Tel +8613607916298, Email Background: We established a nomogram for ketosis-prone type 2 diabetes mellitus (KP-T2DM) in the Chinese adult population in order to identify high-risk groups early and intervene in the disease progression in a timely manner. Methods: We reviewed the medical records of 924 adults with newly diagnosed T2DM from January 2018 to June 2021. All patients were randomly divided into the training and validation sets at a ratio of 7:3. The least absolute shrinkage and selection operator regression analysis method was used to screen the predictors of the training set, and the multivariable logistic regression analysis was used to establish the nomogram prediction model. We verified the prediction model using the receiver operating characteristic (ROC) curve, judged the model's goodness-of-fit using the Hosmer-Lemeshow goodness-of-fit test, and predicted the risk of ketosis using the decision curve analysis. Results: A total of 21 variables were analyzed, and four predictors—hemoglobin A1C, 2-hour postprandial blood glucose, 2-hour postprandial C-peptide, and age—were established. The area under the ROC curve for the training and validation sets were 0.8172 and 0.8084, respectively. The Hosmer-Lemeshow test showed that the prediction model and validation set have a high degree of fit. The decision curve analysis curve showed that the nomogram had better clinical applicability when the threshold probability of the patients was 0.03– 0.79. Conclusion: The nomogram based on hemoglobin A1C, 2-hour postprandial blood glucose, 2-hour postprandial C-peptide, and age has good performance and can serve as a favorable tool for clinicians to predict KP-T2DM. Keywords: diabetic ketoacidosis, nomogram, prediction model, ketosis-prone type 2 diabetes mellitus Some diabetics have spontaneous ketosis or diabetic ketoacidosis (DKA) at onset, often lacking evidence of islet cell autoimmunity, with clinical features similar to those of type 2 diabetes mellitus (T2DM). In recent years, this has been termed as ketosis-prone T2DM (KP-T2DM) and is a group of heterogeneous diseases. 1 Previous research have suggested that KP-T2DM is closely relevant to A-β+ ketosis-prone diabetes (KPD) according to the currently recognized "Aβ" classification scheme, which can accurately predict long-term blood glucose performance and islet cell function. 2 Similar to A-β+ KPD, KP-T2DM is more sensitive to glucotoxicity, and hyperglycemia during the first episode of ketosis leads to a temporary and sharp decline in islet β-cell function, which can initially be improved with insulin treatment and can also be recovered. Insulin therapy is not required for a long period of time and is followed by an inevitable decline in insulin dependence, presenting clinical features different from those of classic T2DM. 3 Despite rapid progress in the diagnosis and treatment of diabetes, DKA still has a high mortality rate in developing countries. 4,5 A Chinese study suggested that the prevalence of diabetic ketosis without acidosis (DKWA) was significantly higher than that of DKA in patients with KP-T2DM; however, patients with DKWA are usually asymptomatic, making DKWA difficult to identify, which can lead to worse outcomes. 6 In the past, KP-T2DM was common in African- American and Hispanic populations. Among African-American and Hispanic patients with newly diagnosed DKA, the prevalence of KP-T2DM was estimated to be between 20% and 50%. 7–9 With the worldwide prevalence of T2DM, an increasing number of cases of KP-T2DM have been reported. Seok et al found that patients with T2DM with ketosis onset accounted for 35% of patients with new-onset diabetes in the Korean population. 3 Similar illnesses had been reported in young adults in Japan. 10 In urban China, patients with KPD under the age of 35 accounted for 7.6% of all patients with diabetes. 11 The epidemiological data of diabetes in China in 2020 show that the prevalence of diabetes among Chinese adults is 12.8%, and is on the rise. 12 Thus, patients with KP-T2DM may become a huge proportion of patients with diabetes in China in the future. We collected the medical rec -Abstract Truncated-
endocrinology & metabolism